Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol

The Journal of Clinical Endocrinology and Metabolism
Gregory A NicholsSergio Fazio

Abstract

Real-world evidence of the relationship between high triglyceride (TG) levels and cardiovascular (CV) disease (CVD) risk among statin-treated patients with low-density lipoprotein cholesterol (LDL-C) control is lacking. We aimed to compare CVD and mortality risk between patients with high vs normal TGs. Longitudinal observational cohort study. Integrated delivery system. Patients aged ≥45 years whose TG level was either <150 mg/dL (normal) or between 200 and 499 mg/dL (high) in 2010, were taking only statins, had LDL-C values 40 to 100 mg/dL, and had diagnosed CVD. Patients were followed through December 2016. Our primary outcomes were a composite of nonfatal myocardial infarction (MI), nonfatal stroke, unstable angina, coronary revascularization, and all-cause mortality and a second composite adding peripheral revascularization and aneurysm repair. We compared multivariable-adjusted incidence rates and rate ratios (RRs) of the outcomes and their components. A total of 14,481 patients comprised the normal TG group, and 2702 patients were in the high TG group. Multivariable-adjusted incidence of the second composite was 10% greater in the high TG group [50.9/1000 person-years, 95% CI 47.0 to 55.2 vs 46.5, 44.8 to 48.2, RR 1.10, ...Continue Reading

References

May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 13, 2001·The American Journal of Cardiology·E J SchaeferJ J Rubenstein
May 14, 2003·Archives of Internal Medicine·Lynn E EberlyUNKNOWN Multiple Risk Factor Intervention Trial Research Group
Oct 20, 2004·Circulation·A PatelUNKNOWN Asia Pacific Cohort Studies Collaboration
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Sandeep BansalPaul M Ridker
Feb 19, 2008·Journal of the American College of Cardiology·Michael MillerUNKNOWN PROVE IT-TIMI 22 Investigators
Jun 4, 2008·Circulation·John J P KasteleinUNKNOWN IDEAL Study Group
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Mar 25, 2009·Archives of Internal Medicine·Earl S FordAli H Mokdad
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
Jun 19, 2010·The New England Journal of Medicine·Robert W YehAlan S Go
Apr 20, 2011·Circulation·Michael MillerUNKNOWN Council on the Kidney in Cardiovascular Disease
Sep 11, 2012·The Journal of Clinical Endocrinology and Metabolism·Lars BerglundUNKNOWN Endocrine society
May 15, 2013·Journal of the American College of Cardiology·Gregory A NicholsShreekant Parasuraman
Jul 12, 2014·The New England Journal of Medicine·UNKNOWN HPS2-THRIVE Collaborative GroupJane Armitage
Oct 16, 2014·World Journal of Diabetes·Pedro ValdivielsoCarmen Pérez-López
Dec 5, 2014·Cardiovascular Diabetology·Alexander TenenbaumEnrique Z Fisman
May 30, 2015·Journal of the American College of Cardiology·Gregory G SchwartzAnders G Olsson
Mar 12, 2016·Journal of the American College of Cardiology·Steven L DriverNeil J Stone
May 18, 2016·The American Journal of Cardiology·Matthew Budoff
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Dec 14, 2016·JAMA : the Journal of the American Medical Association·Laura Dwyer-LindgrenChristopher J L Murray
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 16, 2017·Clinical Cardiology·Deepak L BhattUNKNOWN REDUCE-IT Investigators
Apr 25, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul S JellingerMichael Davidson
Jul 18, 2017·JAMA : the Journal of the American Medical Association·Jonathan P JarowJanet Woodcock
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Oct 18, 2018·Expert Review of Clinical Pharmacology·Bogusław OkopieńAleksandra Bołdys
Feb 27, 2019·Current Diabetes Reports·Anastasia-Stefania AlexopoulosJohn R Guyton
Nov 20, 2019·Diabetes, Obesity & Metabolism·Peter P TothGregory A Nichols
May 3, 2019·Current Opinion in Lipidology·Sara Coles, Richard A Krasuski
Dec 27, 2019·Current Opinion in Lipidology·Atul Kalhan
Dec 17, 2019·Current Treatment Options in Cardiovascular Medicine·Daniel C Brooks, Joseph L Schindler
Jun 25, 2020·International Journal of Preventive Medicine·Alireza JabbariMohammad Ghasemi
Jun 11, 2020·Journal of Clinical Medicine·Pilar SanchisLuis Masmiquel
Nov 13, 2018·The New England Journal of Medicine·Deepak L BhattUNKNOWN REDUCE-IT Investigators
Jan 16, 2021·Pharmacogenomics and Personalized Medicine·Pornpen SrisawasdiMartin H Kroll
Jan 29, 2021·Journal of Lipids·Muhammad Shoaib KhanRobert W W Biederman
Dec 18, 2020·Frontiers in Cardiovascular Medicine·Dong MaYong-Bo Zhao
Aug 26, 2021·Critical Pathways in Cardiology·Jelena SpyropoulosDavid R Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.